United Capital Financial Advisers LLC trimmed its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 40.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,377 shares of the company’s stock after selling 3,636 shares during the period. United Capital Financial Advisers LLC’s holdings in Cardinal Health were worth $337,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in CAH. Boston Partners boosted its position in Cardinal Health by 74.4% during the 1st quarter. Boston Partners now owns 6,095,384 shares of the company’s stock worth $382,059,000 after purchasing an additional 2,599,918 shares during the period. Amundi Pioneer Asset Management Inc. purchased a new position in Cardinal Health in the 4th quarter valued at about $111,944,000. Pzena Investment Management LLC boosted its position in Cardinal Health by 47.3% in the 1st quarter. Pzena Investment Management LLC now owns 2,873,639 shares of the company’s stock valued at $180,120,000 after buying an additional 923,179 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its position in Cardinal Health by 63.1% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 2,206,023 shares of the company’s stock valued at $138,274,000 after buying an additional 853,062 shares during the last quarter. Finally, Element Capital Management LLC purchased a new position in Cardinal Health in the 4th quarter valued at about $43,493,000. 91.92% of the stock is owned by hedge funds and other institutional investors.
Shares of Cardinal Health opened at $48.83 on Friday, Marketbeat.com reports. The company has a current ratio of 1.10, a quick ratio of 0.54 and a debt-to-equity ratio of 1.20. Cardinal Health Inc has a one year low of $48.28 and a one year high of $78.89. The stock has a market cap of $15.65 billion, a PE ratio of 9.04, a P/E/G ratio of 1.51 and a beta of 0.99.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, May 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.51 by ($0.12). Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. The company had revenue of $33.63 billion for the quarter, compared to the consensus estimate of $33.61 billion. analysts anticipate that Cardinal Health Inc will post 4.92 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Sunday, July 15th. Stockholders of record on Monday, July 2nd will be given a dividend of $0.476 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.46. The ex-dividend date is Friday, June 29th. This represents a $1.90 annualized dividend and a dividend yield of 3.90%. Cardinal Health’s dividend payout ratio (DPR) is presently 34.26%.
A number of equities analysts have weighed in on CAH shares. Zacks Investment Research cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Barclays started coverage on shares of Cardinal Health in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $74.00 price objective for the company. TheStreet raised shares of Cardinal Health from a “c+” rating to a “b-” rating in a research report on Tuesday, March 13th. Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $85.00 price objective for the company in a research report on Monday, April 2nd. Finally, Leerink Swann raised shares of Cardinal Health from a “market perform” rating to an “outperform” rating and set a $75.00 price objective for the company in a research report on Tuesday, April 24th. Five research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $69.79.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.